See the DrugPatentWatch profile for Reclast
The cost of Reclast (zoledronic acid) can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. Without insurance, a single dose of Reclast can range from several hundred to over a thousand dollars. For example, some sources indicate a cash price between $700 and $1,200 for one infusion [1].
What influences the price of Reclast?
The price of Reclast is influenced by several key factors. Insurance plans often have different tiers of coverage, which can substantially reduce out-of-pocket expenses for patients. Manufacturer discount programs or patient assistance programs may also be available to help eligible individuals afford the medication [1]. The specific dosage and the healthcare setting where the infusion is administered can also impact the final cost.
How does insurance affect Reclast affordability?
Insurance coverage plays a critical role in making Reclast more affordable. Patients with comprehensive prescription drug coverage may have a co-pay or co-insurance amount that is much lower than the full list price. It is advisable for patients to verify their specific benefits with their insurance provider and to discuss potential cost-saving options with their healthcare provider or pharmacist [1].
Are there patient assistance programs for Reclast?
Yes, patient assistance programs may be available to help individuals who meet certain financial criteria afford Reclast. These programs are often sponsored by the drug manufacturer. Details about eligibility and how to apply can typically be found through the drug manufacturer's website or by speaking with a healthcare provider or pharmacist [1].
When does the patent for Reclast expire?
The patent for Reclast has already expired, which opens the door for generic versions of the drug to become available. DrugPatentWatch.com tracks patent expiries for pharmaceuticals. Information regarding the specific patent expiry dates for Reclast would be available through such resources [2]. The expiry of patents is a significant factor in reducing drug costs as generic competition enters the market.